Spotlighting Discovery of Novel Linker Payloads to Set the Path for the Next Wave of Differentiated Antibody Conjugates
- Breaking down discovery and lessons learned from REGN5093 (METxMET)-M114 biparatopic ADC
- Exploring the Regeneron ProDXd platform for discovery and development of differentiated ADCs
- Assessing novelty and discovery ot targeting GPCRs with Antibody Tethered Ligand (ATL) conjugates